High Yield Markets
  • World News
  • Politics
  • Investing
  • Stock
  • Editor’s Pick
Politics

New Peer-Reviewed Study Finds Pfizer’s Covid-19 Vaccine Protection Against Omicron Wanes Just a Week After Receiving Second and Third Dose

by May 16, 2022
May 16, 2022

A new peer-reviewed study found that the protection from Pfizer’s Covid-19 vaccine against the Omicron variant fades in just a week after receiving the second and third dose.

According to the Danish study published in JAMA Network on Friday, the researchers found a rapid decline in Omicron-specific serum neutralizing antibody titers only a few weeks after the second and third doses of Pfizer’s Covid-19 vaccine.

The study included 128 Danish adults that were vaccinated. Of the 128,  73 individuals received 2 doses of Pfizer vaccine and 55 received 3 doses of Pfizer (BNT162b2) between January 2021 and October 2021 or were previously infected prior to February 2021 and then vaccinated.

More from Forbes:

Levels of omicron-specific “neutralizing” antibodies—which can target the virus and stop it from replicating—decline rapidly after a second and third dose of Pfizer’s shot, according to the Danish study of 128 people who had received two or three doses.

Antibody levels, which are associated with protection against infection and disease, fell within weeks of getting the shots and were much lower than the level of antibodies specific to the original and delta coronavirus variants, the researchers said.

Compared to original and delta variants, the proportion of omicron-specific antibodies detected in participants’ blood dropped “rapidly” from 76% four weeks after the second shot to 53% at weeks eight to 10 and 19% at weeks 12 to 14, the researchers found.

Omicron-specific antibody levels increased after the third dose—nearly 21-fold at week three and nearly 8-fold at week four, compared to four weeks after the second dose—and the shot generated a detectable response in most people for at least eight weeks, the researchers said.

However, antibody levels started to drop as early as three weeks after the booster shot, falling 4.9-fold for the original variant, 5.6-fold for delta and 5.4-fold for omicron between weeks three and eight.

You can read and download the study here.

The post New Peer-Reviewed Study Finds Pfizer’s Covid-19 Vaccine Protection Against Omicron Wanes Just a Week After Receiving Second and Third Dose appeared first on The Gateway Pundit.

previous post
Pence to Campaign with Dirtbag Brian Kemp Today in Georgia
next post
“Hollywood is Not America” – Katy Perry Moves Out from Hollywood ‘Bubble’ to Live in Kentucky

You may also like

White House Press Sec Comments on Biden’s Low...

August 14, 2022

Saint Louis Patriots Led by TGP’s Jim Hoft...

August 14, 2022

British Man Restrains Woman Who Stripped Down to...

August 14, 2022

Bill Maher Takes Aim at the Term ‘Islamophobic,’...

August 14, 2022

28-Year-Old American National Reportedly Dies Suddenly in a...

August 14, 2022

Energy Sec. Granholm When Asked What Bidenflation Bill...

August 14, 2022

FBI Made a Big Mistake: Trump Rallies Happening...

August 14, 2022

At Mike Lindell’s “Amazon Rival” MyStore: The New...

August 14, 2022

San Francisco Test Running Trash Cans That Cost...

August 14, 2022

Florida School District Will Have Resource Officers Carrying...

August 14, 2022
Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

  • The New Deal and Recovery, Part 20, Coda: The Fate of Rosie the Riveter

    August 11, 2022
  • The New Deal and Recovery, Part 20, Appendix: The Fate of Rosie the Riveter

    August 11, 2022
  • The New Deal and Recovery, Part 20: The Phantom Depression

    August 9, 2022
  • Multi-Millionaire Trader Explains Why You Should Start Trading With A Small Account {VIDEO}

    July 31, 2022
  • Why I Cut $BXMI

    July 29, 2022
  • About Us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Copyright © 2022 HighYieldMarkets.com All Rights Reserved.

High Yield Markets
  • World News
  • Politics
  • Investing
  • Stock
  • Editor’s Pick